SMS Pharmaceuticals Limited (NSE:SMSPHARMA)

India · Delayed Price · Currency is INR

367.90

+0.40 (0.11%)

Feb 18, 2026, 1:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical Products Including Ingredients and Intermediaries	7.83B	7.09B	5.22B	5.20B	5.63B
Pharmaceutical Products Including Ingredients and Intermediaries Growth	10.36%	35.86%	0.42%	-7.69%	35.93%
Total	7.83B	7.09B	5.22B	5.20B	5.63B
Total Growth	10.36%	35.86%	0.42%	-7.69%	35.93%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Exports	5.43B	5.09B	3.26B	3.27B	3.39B
Exports Growth	6.67%	56.18%	-0.32%	-3.67%	124.79%
India	2.40B	2.00B	1.64B	1.42B	1.31B
India Growth	19.72%	22.14%	15.92%	7.71%	47.67%
Deemed Exports	-	-	197.32M	466.34M	901.16M
Deemed Exports Growth	-	-	-57.69%	-48.25%	-46.17%
Unallocated	-	-	124.32M	48.59M	23.60M
Unallocated Growth	-	-	155.89%	105.85%	-48.71%
Total	7.83B	7.09B	5.22B	5.20B	5.63B
Total Growth	10.36%	35.86%	0.42%	-7.69%	36.71%

Source: S&P Global Market Intelligence.